Profile | GDS5420 / 205424_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 200.06 | 52 |
GSM1296119 | B_lesional_pre-dose | 47.03 | 28 |
GSM1296076 | C_lesional_pre-dose | 55.11 | 32 |
GSM1296092 | D_lesional_pre-dose | 65.14 | 37 |
GSM1296103 | E_lesional_pre-dose | 141.91 | 47 |
GSM1296078 | F_lesional_pre-dose | 47.14 | 30 |
GSM1296107 | G_lesional_pre-dose | 106.77 | 41 |
GSM1296109 | H_lesional_pre-dose | 157.88 | 47 |
GSM1296080 | I_lesional_pre-dose | 64.43 | 36 |
GSM1296090 | J_lesional_pre-dose | 51.45 | 33 |
GSM1296074 | K_lesional_pre-dose | 54.25 | 34 |
GSM1296111 | L_lesional_pre-dose | 71.33 | 33 |
GSM1296099 | M_lesional_pre-dose | 157.21 | 48 |
GSM1296086 | O_lesional_pre-dose | 67.29 | 37 |
GSM1296117 | P_lesional_pre-dose | 128.84 | 44 |
GSM1296113 | Q_lesional_pre-dose | 139.96 | 44 |
GSM1296096 | R_lesional_pre-dose | 102.78 | 42 |
GSM1296105 | S_lesional_pre-dose | 160.44 | 48 |
GSM1296098 | T_lesional_pre-dose | 145.75 | 47 |
GSM1296101 | U_lesional_pre-dose | 166.24 | 49 |
GSM1296121 | V_lesional_pre-dose | 69.91 | 35 |
GSM1296088 | W_lesional_pre-dose | 64.85 | 36 |
GSM1296082 | X_lesional_pre-dose | 47.94 | 32 |
GSM1296115 | Y_lesional_pre-dose | 97.7 | 40 |
GSM1296084 | Z_lesional_pre-dose | 66.23 | 35 |
GSM1296072 | B_lesional_day8 | 98.25 | 40 |
GSM1296069 | L_lesional_day8 | 93.22 | 37 |
GSM1296071 | P_lesional_day8 | 123.27 | 42 |
GSM1296070 | Y_lesional_day8 | 130.36 | 43 |
GSM1296073 | V_lesional_day8 | 51 | 30 |
GSM1296034 | A_lesional_day15 | 302.75 | 58 |
GSM1296041 | G_lesional_day15 | 107.03 | 41 |
GSM1296035 | R_lesional_day15 | 128.03 | 46 |
GSM1296038 | U_lesional_day15 | 144.37 | 47 |
GSM1296047 | B_lesional_day15 | 93.58 | 38 |
GSM1296039 | E_lesional_day15 | 99.7 | 42 |
GSM1296042 | H_lesional_day15 | 120.2 | 42 |
GSM1296043 | L_lesional_day15 | 139.7 | 44 |
GSM1296037 | M_lesional_day15 | 160.82 | 48 |
GSM1296046 | P_lesional_day15 | 91.73 | 37 |
GSM1296044 | Q_lesional_day15 | 88.61 | 37 |
GSM1296045 | Y_lesional_day15 | 88.43 | 36 |
GSM1296025 | C_lesional_day15 | 149.52 | 48 |
GSM1296033 | D_lesional_day15 | 106.26 | 43 |
GSM1296027 | I_lesional_day15 | 60.71 | 36 |
GSM1296032 | J_lesional_day15 | 111.13 | 43 |
GSM1296024 | K_lesional_day15 | 93.75 | 41 |
GSM1296031 | W_lesional_day15 | 98.72 | 40 |
GSM1296028 | X_lesional_day15 | 78.64 | 38 |
GSM1296029 | Z_lesional_day15 | 124.41 | 45 |
GSM1296026 | F_lesional_day15 | 92.09 | 41 |
GSM1296030 | O_lesional_day15 | 51.31 | 34 |
GSM1296040 | S_lesional_day15 | 137.73 | 46 |
GSM1296036 | T_lesional_day15 | 205.98 | 52 |
GSM1296048 | V_lesional_day15 | 67.67 | 34 |
GSM1296059 | A_lesional_day43 | 205.89 | 53 |
GSM1296066 | G_lesional_day43 | 92.86 | 38 |
GSM1296060 | R_lesional_day43 | 149.96 | 48 |
GSM1296063 | U_lesional_day43 | 115.66 | 43 |
GSM1296064 | E_lesional_day43 | 96.14 | 41 |
GSM1296067 | H_lesional_day43 | 153.82 | 46 |
GSM1296062 | M_lesional_day43 | 196.46 | 52 |
GSM1296068 | Q_lesional_day43 | 103.45 | 38 |
GSM1296050 | C_lesional_day43 | 107.71 | 42 |
GSM1296057 | D_lesional_day43 | 155.62 | 48 |
GSM1296052 | I_lesional_day43 | 39.28 | 29 |
GSM1296054 | J_lesional_day43 | 134.11 | 45 |
GSM1296049 | K_lesional_day43 | 117.3 | 44 |
GSM1296055 | W_lesional_day43 | 129.93 | 44 |
GSM1296053 | X_lesional_day43 | 77.95 | 38 |
GSM1296058 | Z_lesional_day43 | 175.01 | 51 |
GSM1296051 | F_lesional_day43 | 37.07 | 26 |
GSM1296056 | O_lesional_day43 | 120.47 | 46 |
GSM1296065 | S_lesional_day43 | 126.14 | 45 |
GSM1296061 | T_lesional_day43 | 249.23 | 55 |
GSM1296095 | A_non-lesional_pre-dose | 95.7 | 41 |
GSM1296120 | B_non-lesional_pre-dose | 81.3 | 36 |
GSM1296077 | C_non-lesional_pre-dose | 99.48 | 42 |
GSM1296093 | D_non-lesional_pre-dose | 92.04 | 39 |
GSM1296104 | E_non-lesional_pre-dose | 122.81 | 44 |
GSM1296079 | F_non-lesional_pre-dose | 91.77 | 40 |
GSM1296108 | G_non-lesional_pre-dose | 120.92 | 43 |
GSM1296110 | H_non-lesional_pre-dose | 91.31 | 37 |
GSM1296081 | I_non-lesional_pre-dose | 70.17 | 38 |
GSM1296091 | J_non-lesional_pre-dose | 69.58 | 37 |
GSM1296075 | K_non-lesional_pre-dose | 60.88 | 34 |
GSM1296112 | L_non-lesional_pre-dose | 130.23 | 42 |
GSM1296100 | M_non-lesional_pre-dose | 216.25 | 53 |
GSM1296087 | O_non-lesional_pre-dose | 27.5 | 24 |
GSM1296118 | P_non-lesional_pre-dose | 130.09 | 43 |
GSM1296114 | Q_non-lesional_pre-dose | 130.97 | 43 |
GSM1296097 | R_non-lesional_pre-dose | 101.47 | 41 |
GSM1296106 | S_non-lesional_pre-dose | 140.15 | 45 |
GSM1296102 | U_non-lesional_pre-dose | 210 | 52 |
GSM1296122 | V_non-lesional_pre-dose | 102.58 | 40 |
GSM1296089 | W_non-lesional_pre-dose | 77.67 | 36 |
GSM1296083 | X_non-lesional_pre-dose | 127.29 | 45 |
GSM1296116 | Y_non-lesional_pre-dose | 105.98 | 39 |
GSM1296085 | Z_non-lesional_pre-dose | 49.19 | 31 |